Home > Healthcare > Biotechnology > Biotechnology R&D > In-vitro Transcription Templates Market

In-vitro Transcription Templates Market Size

Report ID: GMI9684
Published Date: May 2024
Report Format: PDF

Download Free Sample

In-vitro Transcription Templates Market Size

In-vitro Transcription Templates Market size was valued at around USD 277.7 million in 2023 and is estimated to grow at 19.6% CAGR from 2024 to 2032. In-vitro transcription templates are DNA sequences used to synthesize RNA molecules in a controlled laboratory environment, outside of living cells. These templates contain specific promoter sequences recognized by RNA polymerases, which initiate the transcription process to produce RNA.

To get key market trends

Download Free Sample

The increasing demand for mRNA vaccines and therapeutics, particularly highlighted by the rapid development and deployment of COVID-19 vaccines, has significantly advanced the field of in-vitro transcription templates. This surge in demand has led to innovations in template design such as optimizing promoter sequences and incorporating regulatory elements to enhance mRNA yield and stability. Additionally, scalable production methods and stringent quality control measures are now crucial to meet the high volume and purity requirements for therapeutic applications. These advancements ensure efficient, high-quality mRNA synthesis, essential for the effectiveness and safety of mRNA-based therapeutics and vaccines.

Furthermore, advancements in genomics and transcriptomics and ongoing research in genomics and molecular biology fuels the demand for high-quality mRNA for various experimental purposes, further driving the market for in-vitro transcription templates.

In-vitro Transcription Templates Market Report Attributes
Report Attribute	Details
Base Year:	2023
In-vitro Transcription Templates Market Size in 2023:	USD 277.7 million
Forecast Period:	2024 – 2032
Forecast Period 2024 – 2032 CAGR:	19.6%
2024 – 2032 Value Projection:	USD 1.3 Billion
Historical Data for:	2021 – 2023
No. of Pages:	301
Tables, Charts & Figures:	369
Segments covered:	Product Type, Disease, Treatment, Research Stage, End-use, and Region
Growth Drivers:	Advancements in genomics and transcriptomics Increasing demand for mRNA vaccines and therapeutics Research and development in molecular biology
Pitfalls & Challenges:	Limited accessibility and affordability Stringent regulatory challenges

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

In-vitro transcription templates industry size was worth USD 277.7 million in 2023 and is projected to expand at 19.6% CAGR from 2024 to 2032, owing to the increasing demand for mRNA vaccines and therapeutics.

The DNA templates product segment in the in-vitro transcription templates industry is projected to record USD 571.9 million by 2032, as these templates are highly efficient in driving transcription.

The cancer disease segment in the in-vitro transcription templates industry accounted for USD 90.5 million in 2023 and is projected grow at significant rate from 2024 to 2032, as they are useful for generating large quantities of RNA for functional studies such as examining the roles of oncogenes or tumor suppressor genes in cancer development.

U.S. in-vitro transcription templates industry is projected to reach USD 213.9 million by 2032, led by the strong presence of world-class research institutions, academic centers, and biotechnology hubs for innovation in molecular biology.